Promising Study Results Propel Xeris Biopharma (XERS) Stock Upward
Upon the announcement of favorable topline study data, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) experienced a notable upward trend in its share price this morning. At the latest check during the current trading session, XERS stock had risen by 15.84%, reaching $2.24. Promising Phase 2 Study Results Xeris Biopharma (XERS) disclosed topline outcomes from its […]